Skip to content
TradeSmith
  • Log In
  • Products
  • Research
  • About
  • Log In

Get an Edge This Holiday Weekend with LikeFolio’s Best for Earnings Season

TradeSmith Editorial Staff April 7, 2023

Everything from their “Earnings Cheat Sheet,” to building a powerful decision-making process framework, to what to expect from a few individual companies; it’s all here for you.

Read now

6 Investable Consumer Trends to Know Today for Earnings Season

TradeSmith Editorial Staff April 4, 2023

From AI to cruises, there will be plenty of moneymaking opportunities…

Read now

How to Be a Short-Term Bear and a Long-Term Bull and Make Money

TradeSmith Editorial Staff April 3, 2023

It’s why some professional traders have labeled this upcoming earnings season as the 40 most important days of the investing year.

Read now

Turning Earnings Season into Profit Season This April

TradeSmith Editorial Staff March 29, 2023

40 of the most profitable days of the year...

Read now

If You’re Selling, I’m Buying: The Nvidia Profit Opportunity in 3 Charts

TradeSmith Editorial Staff March 24, 2023

Looking at both TradeSmith’s tools and Jason’s proprietary system, we can dive into the profitable situation building up for NVDA through three charts.

Read now

The Data Point That Matters the Most for the Direction of the Stock Market

TradeSmith Editorial Staff March 14, 2023

As I was talking with Quantum Edge Pro Editor Jason Bodner about all this, he assured me that there was no need to suffer from information overload, as he believes just one data point should be focused on the most.

Read now

One Company at the Frontier of Gene-Editing Technology (Ticker Revealed Inside)

TradeSmith Editorial Staff March 9, 2023

Imagine how much money could be made by investing in companies that could provide lifelong cures to genetic conditions. With this company, you may not have to imagine.

Read now

Gene-Editing Collaboration Is What’s Next for Moderna – Here’s What TradeSmith’s Tools Say about the Stock

TradeSmith Editorial Staff March 8, 2023

Now, to be clear, biotech investing is notoriously risky, as it can cost hundreds of millions of dollars and years to develop a product that ultimately may not pass FDA approval. But with TradeSmith’s tools and proprietary algorithms, we’re able to help our readers go past the news and measure what ultimately matters.

Read now

Ford Launches Artificial Intelligence Subsidiary – Here’s How to Know if the Carmaker Is a Buy

TradeSmith Editorial Staff March 7, 2023

Ford Motor Co. (F) announced on March 2 the creation of Latitude AI, a wholly owned subsidiary that will develop automated driving technology that focuses on a “hands-free, eyes-off driver assist system for next-generation Ford vehicles.”

Read now

The Company Behind This $10,000 Artificial Intelligence Chip Just Flashed a Buy Signal

TradeSmith Editorial Staff March 2, 2023

According to our Health Indicator, this company just triggered a buy signal, entering the Green Zone on Feb. 21. Here's everything you need to know.

Read now
TradeSmith

Have a question about your service?

Toll free: (866) 385-2076

Hours: Monday – Friday 9 am – 5 pm (Eastern)

Email: [email protected]

Products

  • All Products
  • Investment Tools
  • Trading & Income
  • Cryptocurrency
  • Macro Investing
  • Quant-Based Research

Research

  • All Posts
  • TradeSmith Daily

Top Indexes

  • S&P 500
  • DOW 30
  • NASDAQ 100
  • Russell 2000
  • Russell 1000
  • S&P 400
  • S&P 600

Top Stocks

  • Apple
  • Microsoft
  • NVIDIA
  • Toyota Motor Sp ADR
  • Amazon.com
  • Meta Platforms-A
  • Tesla
  • Privacy Policy
  • Ad Choices
  • Do Not Sell My Information
  • Cookie Policy
  • Cookie Preferences
  • DMCA policy
  • Terms of Use
  • Careers

© 2026 TradeSmith. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.